Cormark Decreases Earnings Estimates for Ascend Wellness

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Cormark cut their FY2025 earnings per share estimates for shares of Ascend Wellness in a report issued on Wednesday, November 12th. Cormark analyst J. Pytlak now anticipates that the company will post earnings per share of ($0.46) for the year, down from their previous forecast of ($0.44). The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.40) per share.

Separately, Zacks Research upgraded shares of Ascend Wellness from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Ascend Wellness Stock Down 4.8%

Shares of Ascend Wellness stock traded down $0.03 during trading on Friday, hitting $0.60. 54,588 shares of the stock traded hands, compared to its average volume of 168,782. Ascend Wellness has a 52-week low of $0.26 and a 52-week high of $0.98. The stock’s fifty day simple moving average is $0.75 and its 200 day simple moving average is $0.54. The firm has a market cap of $122.67 million, a P/E ratio of -1.46 and a beta of 1.12. The company has a current ratio of 1.47, a quick ratio of 0.80 and a debt-to-equity ratio of 2.61.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.